Biodistribution and tumor imaging of an anti-CEA single-chain antibody–albumin fusion protein
- 29 February 2008
- journal article
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 35 (2), 151-158
- https://doi.org/10.1016/j.nucmedbio.2007.10.010
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Pilot Trial Evaluating an 123I-Labeled 80-Kilodalton Engineered Anticarcinoembryonic Antigen Antibody Fragment (cT84.66 Minibody) in Patients with Colorectal CancerClinical Cancer Research, 2004
- Humanization of the anti-CEA T84.66 antibody based on crystal structure dataProtein Engineering, Design and Selection, 2004
- Tumor targeting based on the effect of enhanced permeability and retention (EPR) and the mechanism of receptor-mediated endocytosis (RME)International Journal of Pharmaceutics, 2004
- Engineering Multivalent Antibody Fragments for In Vivo TargetingPublished by Springer Nature ,2003
- Expression of Recombinant Antibodies in Mammalian Cell LinesPublished by Springer Nature ,2003
- The Crystal Structure of an Anti-CEA scFv Diabody Assembled from T84.66 scFvs in VL-to-VH Orientation: Implications for Diabody FlexibilityJournal of Molecular Biology, 2003
- Albumin Binding as a General Strategy for Improving the Pharmacokinetics of ProteinsJournal of Biological Chemistry, 2002
- Tumor localization of anti-CEA single-chain Fvs: improved targeting by non-covalent dimersImmunotechnology, 1996
- Binding of Serum Albumin on Tumor Cells and Characterization of the Albumin Binding ProteinThe Journal of Biochemistry, 1994
- Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extensionGene, 1989